Methenamine Hippurate is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Corepharma, Llc. The primary component is Methenamine Hippurate.
Product ID | 64720-139_53780aec-180c-424b-ba92-c07a1cbf6203 |
NDC | 64720-139 |
Product Type | Human Prescription Drug |
Proprietary Name | Methenamine Hippurate |
Generic Name | Methenamine Hippurate |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2003-07-01 |
Marketing End Date | 2020-02-01 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA076411 |
Labeler Name | CorePharma, LLC |
Substance Name | METHENAMINE HIPPURATE |
Active Ingredient Strength | 1 g/1 |
NDC Exclude Flag | N |
Marketing Start Date | 2003-07-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA076411 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2003-07-01 |
Marketing End Date | 2020-02-01 |
Ingredient | Strength |
---|---|
METHENAMINE HIPPURATE | 1 g/1 |
SPL SET ID: | ad741dc5-816c-4ab2-9273-9b1a586149bc |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0115-1754 | Methenamine Hippurate | Methenamine Hippurate |
0955-1037 | Methenamine Hippurate | Methenamine Hippurate |
42571-332 | Methenamine Hippurate | Methenamine Hippurate |
43199-020 | Methenamine Hippurate | Methenamine Hippurate |
47781-577 | Methenamine Hippurate | Methenamine Hippurate |
50268-549 | Methenamine Hippurate | Methenamine Hippurate |
50742-142 | METHENAMINE HIPPURATE | methenamine hippurate |
60687-694 | Methenamine Hippurate | Methenamine Hippurate |
64720-139 | Methenamine Hippurate | Methenamine Hippurate |
65862-782 | Methenamine Hippurate | Methenamine Hippurate |
68151-0984 | Methenamine Hippurate | Methenamine Hippurate |
69315-210 | Methenamine Hippurate | Methenamine Hippurate |
30698-277 | HIPREX | Methenamine Hippurate |
30698-477 | HIPREX | Methenamine Hippurate |